Press release
Biosimilars Market Growth Rate and Share Analysis 2022- Biocon, Eli Lilly and Company, Sanofi
The biosimilar insulin market reached US$ 1.3 Bn at the end of 2021 and is expected to surge ahead at a CAGR of 14.9% over the forecast period (2022-2032). As biologics manufacturing in emerging countries has increased, the global pharmaceutical industry has become even more competitive. Companies in these fields will need to constantly upgrade their specialized manufacturing skills to stay relevant.Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/11674
Funding in biotechnology will continue to drive a significant portion of the industry, with biologics accounting for an increasing proportion of leading pharmaceuticals. The requirement for biosimilar insulin is increasing at a rapid rate to meet the needs of the growing diabetic population. With recent approvals of some biosimilar insulin products, manufacturers are trying to increase their production capacity keeping in mind product effectiveness, safety, and ease of administration.
Biologic products must adhere to strict regulations and laws; thus, the supply isn't enough to meet demand. There are only a few approved biosimilar insulin products available. The regulatory guidelines for phase-appropriate production process studies for clinical supplies are beneficial in the case of biosimilar insulin.
The biosimilar insulin industry has grown due to increased advancements in insulin management systems. Growing demand for insulin and the rising population dealing with diabetes are driving manufacturers, and also new entrants, to develop innovative products. Additionally, growing healthcare costs and increased R&D efforts have fueled biosimilar insulin market expansion.
The COVID-19 pandemic increased the risk of diabetes diagnosis after contracting the virus, prompting pharmaceutical companies to invest in biosimilar insulin facilities and meet the rising demand.
Company Profiles:
Biocon
Eli Lilly and Company
Sanofi
BGP Pharma
Aspen
Mylan (Viatris)
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/11674
Key Takeaways from Market Study
The biosimilar insulin market is expected to reach 5.9 Bn by 2032.
Insulin glargine held 81.6% market share by product segment in 2021.
By distribution channel, retail pharmacies are making biosimilar insulin widely available, and the segment held a market share of 46.7% in 2021.
Around 69.9% of the global market share, by region, was accounted for by North America in 2021.
"Rising focus on cost-effective manufacturing of effective biologics and increasing demand for insulin will drive market growth over the coming years," says an analyst of Persistence Market Research.
Market Competition
Leading players are collaborating to drive down the cost of insulin. This is having a positive impact on the biosimilar insulin market. Manufacturing an efficient product that can be as similar to the original is a challenge, but companies that have years of experience in biologics and insulin are trying their best to keep on going through trials and launch innovative products in the market after FDA approvals.
On 3 March 2022, the Juvenile Diabetes Research Foundation (JDRF) collaborated with Civica to help combat the nationwide insulin affordability crisis. Civica manufactures one long-acting insulin biosimilar - Sanofi's Lantus (insulin glargine), and two rapid-acting insulins.
A collaboration between Mylan N.V. and Momenta Pharmaceuticals, Inc. has provided a competitive advantage to Mylan by increasing the number of insulin biosimilars under development.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the biosimilar insulin market in its latest study, presenting a historical demand assessment of 2017 - 2021 and projections for 2022 - 2032.
The research study is based on product (insulin glargine, insulin analog, and others) and distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), across five key regions of the world.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/11674
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biosimilars Market Growth Rate and Share Analysis 2022- Biocon, Eli Lilly and Company, Sanofi here
News-ID: 2798574 • Views: …
More Releases from Persistence Market Research

Fruit Ingredients Market to Reach US$ 111.3 Bn by 2032, Driven by Rising Health …
Overview of the Global Fruit Ingredients Market
The global fruit ingredients market is witnessing significant growth, driven by rising consumer demand for natural, clean-label, and nutrient-rich food products. In 2025, the market is likely to be valued at US$ 75.0 billion and is expected to reach US$ 111.3 billion by 2032, registering a robust CAGR of 5.8% during the forecast period. Fruit ingredients, which include fruit concentrates, purees, powders, and extracts,…

Vegan Dessert Market to Reach US$ 11.9 Bn by 2032, Driven by Rising Health & Pla …
Overview of the Market
The global vegan dessert market is poised for significant expansion, with an estimated valuation of US$ 5.2 billion in 2025, projected to reach US$ 11.9 billion by 2032. This robust growth reflects a compound annual growth rate (CAGR) of 11.7% during the forecast period from 2025 to 2032. Increasing consumer awareness about health, environmental sustainability, and ethical food consumption is driving the widespread adoption of vegan dessert…

Instant Beverage Premix Market to Reach US$148.3 Bn by 2032 Driven by Convenienc …
Overview of the Global Instant Beverage Premix Market
The global instant beverage premix market has witnessed remarkable growth over the past decade, driven by evolving consumer lifestyles and increasing demand for convenient, ready-to-consume beverages. Instant beverage premixes, encompassing products such as instant coffee, tea, flavored drinks, protein powders, and nutritional supplements, cater to busy consumers seeking quick preparation without compromising on taste or nutritional value. These premixes have gained popularity across…

Dermacosmetics Market to Reach US$ 87.3 Bn by 2032 at 7.4% CAGR: Persistence Mar …
The global dermacosmetics market, estimated at US$ 53 billion in 2025, is forecasted to witness a steady upward trajectory, expanding at a Compound Annual Growth Rate (CAGR) of 7.4% to reach US$ 87.3 billion by 2032. This surge is driven by a confluence of factors ranging from increasing consumer awareness and the rising incidence of skin conditions to a growing preference for advanced, dermatologist-backed skincare solutions. Dermacosmetics, a category that…
More Releases for Mylan
Anastrozole Tablets Market is Booming Worldwide - Teva Pharmaceuticals, Mylan
Anastrozole Tablets Market Insights
The anastrozole tablets market is estimated to be valued at US$ 278.1 million in 2020 and is expected to exhibit a CAGR of 2.8% over the forecast period (2020-2027).
Coherent Market Insights has published a new comprehensive analysis on the Anastrozole Tablets Market (2025-2032), focusing on critical transformations in the U.S. healthcare environment. This report highlights essential metrics including market size, revenue forecasts, CAGR, adoption trends, and regulatory…
Cystinosis Market: Epidemiology, Therapies, Companies, DelveInsight | Horizon Ph …
Cystinosis emerging therapies, such as NPI-001, and others, are expected to boost the Cystinosis Market in the upcoming years.
DelveInsight has launched a new report on "Cystinosis - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Cystinosis, historical and forecasted epidemiology as well as the Cystinosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Cystinosis market…
Oxycodone Market is Booming Worldwide | Pfizer, Apotex, Mylan
The Latest Released Oxycodone market study has evaluated the future growth potential of Global Oxycodone market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision-makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, and emerging trends along with essential drivers, challenges, opportunities,…
Scabies Treatment Market is Thriving Worldwide | Apotex, Mylan, Bayer
The Latest published market study on Global Scabies Treatment Market provides an overview of the current market dynamics in the Scabies Treatment, as well as what our survey respondents all outsourcing decision-makers predict the market will look like in 2032. The study breaks the market by revenue and volume (wherever applicable) and price history to estimate the size and trend analysis and identify gaps and opportunities. Some of the players…
Cabozantinib Market Is Booming Worldwide with Exelixis, Mylan, Sandoz
HTF MI introduces new research on Cabozantinib covering the micro level of analysis by competitors and key business segments (2023-2029). The Cabozantinib explores a comprehensive study of various segments like opportunities, size, development, innovation, sales, and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists of both qualitative and quantitative detailing. Some of the major key players profiled in the…
Global Ambroxol Industry Chain Research Report2022|Bayer, Novartis, Mylan
QY Research has recently published a new report, titled Global Ambroxol Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Ambroxol market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the…